Identifying the inflators and deflators, and the role all stakeholders play.
Philip Sclafani
Advertisement
Pharmaceutical & Life Sciences Lead, PwC
Articles by Philip Sclafani
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Elicio Therapeutics’ Shares Drop Following Announcement of Phase II Trial Results
2
Pharma Roundup: FDA Approves Truqap Plus Abiraterone and Prednisone, FDA Approves Keytruda and Keytruda Qlex Each in Combination with Welireg
3
Partnering in Non-Opioids: Q&A with Dr. Edward Littler and Dave Watson
4
Pharmaceutical Executive Daily: FDA Approves Two Indications of Keytruda in Combination with Welireg
5